Drug · DIN 02237835
BETAJECT
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 1, 2019; first marketed July 2, 1998.
- Drug Identification Number (DIN)
- 02237835
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Intramuscular; Intralesional; Intra-Articular
- Therapeutic class (ATC)
- Betamethasone H02AB01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BETAMETHASONE ACETATE | 3 MG | ML |
| BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) | 3 MG | ML |